1,966 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 799 increasing their positions, 755 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.16B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,966
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
253
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.79B
Puts
$2.95B
Net Calls
Net Calls Change

Top Buyers

1 +$588M
2 +$433M
3 +$411M
4
CM
Corvex Management
New York
+$391M
5
Sanders Capital
Sanders Capital
Florida
+$331M

Top Sellers

1 -$1.43B
2 -$1.39B
3 -$1.31B
4
Franklin Resources
Franklin Resources
California
-$677M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$368M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$597M
52
$594M
53
$592M
54
$591M
55
$586M
56
$579M
57
$565M
58
$563M
59
$542M
60
$529M
61
$516M
62
$506M
63
$497M
64
$471M
65
$462M
66
$441M
67
$440M
68
$428M
69
$424M
70
$424M
71
$414M
72
$402M
73
$401M
74
$390M
75
$385M